cefazolin has been researched along with Disease Models, Animal in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (18.18) | 18.7374 |
1990's | 18 (27.27) | 18.2507 |
2000's | 14 (21.21) | 29.6817 |
2010's | 18 (27.27) | 24.3611 |
2020's | 4 (6.06) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Alamneh, Y; Antonic, V; Bobrov, AG; Deluca, JP; Getnet, D; Long, JB; Nadeau, RJ; Pannone, KM; Pavlovic, R; Rios, KE; Sajja, VS; Selig, DJ; Tyner, S; Vuong, C | 1 |
Alamneh, Y; Antonic, V; Black, C; Demons, S; Garry, B; Long, J; Medina-Rojas, M; Nguyen, K; Potter, B; Sajja, V; Shearer, J; Sousa, J; Tyner, S; Vuong, C; Wilder, D; Zurawski, D | 1 |
Doi, K; Ishie, S; Ito, H; Kuroda, Y; Matsuda, S; Morita, Y; Murata, K; Nishitani, K; Okae, Y; Saito, M; Tomizawa, T; Yoshida, S; Yoshitomi, H | 1 |
Arruebo, M; Asín, J; García-Álvarez, F; Gimeno, M; Luján, L; Mendoza, G; Pérez, M; Pinczowski, P; Santamaría, J; Vázquez, FJ; Vispe, E | 1 |
Dubrovsky, G; Dunn, JCY; Huynh, N; Koulakis, JP; Nicolau, DP; Putterman, S; Rouch, JD; Sutherland, CA | 1 |
Bouchard, M; Shiels, SM; Wang, H; Wenke, JC | 1 |
Liang, P; Shan, W; Zuo, Z | 1 |
Bayraktutan, Z; Bilici, D; Celebi, D; Cinar, I; Kaya, Z; Toktay, E; Yayla, M | 1 |
Baldini, R; Battaglia, G; Bernabucci, M; Ciolli, L; Collini, S; Gradini, R; Macaluso, A; Nicoletti, F; Trabucco, A; Troisi, F | 1 |
Aiba, T; Horiuchi, M; Kurosaki, Y; Moriyama, S; Takahata, Y | 1 |
Cai, WH; Feng, XM; Wang, JC; Yang, JD; Zhang, L; Zhang, N | 1 |
Deniz, K; Günay, GK; Kemaloğlu, CA; Perçin, D | 1 |
Itakura, Y; Iwata, C; Matsushita, R; Miyamoto, K; Taga, S; Teramachi, H; Tsuchiya, H; Wada, T | 1 |
Bahar, I; Gal-Or, O; Pillar, S; Rock, O; Tal, K; Zahavi, A | 1 |
Chen, J; Huo, Z; Jiao, J; Liu, X; Wang, X; Xiong, N; Zheng, H | 1 |
Kumaraswamy, M; Nizet, V; Olson, J; Pogliano, J; Quach, DT; Rybak, MJ; Sakoulas, G; Singh, NB; Yim, J | 1 |
Alcantara-Martos, T; Carrascal, MT; Cobo-Valenzuela, N; Delgado-Martinez, AD; Natividad-Pedreño, M; Nuñez-Chia, A | 1 |
Berry, J; Cavanaugh, DL; Dahners, LE; Yarboro, SR | 1 |
Ai, ZS; Feng, Y; Jia, WT; Wang, JQ; Zhang, CQ | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
Argun, M; Deniz, K; Guney, A; Halici, M; Kafadar, I; Oner, M; Turk, Y | 1 |
Murray, CK; Penn-Barwell, JG; Wenke, JC | 1 |
Ambrose, CG; Clyburn, TA; Gogola, GR; Gulati, P; Joseph, J; Louden, K; Mikos, AG; Wright, J | 1 |
Nikitenko, VI | 1 |
Awaya, T; Chiba, K; Fujimaru, S; Hayase, N; Matsubara, K; Ohtaki, K; Shimizu, K; Shiono, H; Suno, M | 1 |
Balaban, N; Cirioni, O; D'Amato, G; Del Prete, MS; Dell'Acqua, G; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Rocchi, M; Saba, V; Scalise, G; Silvestri, C | 1 |
Gurkan, T; Oguz, E; Oguz, H; Ozbilge, H | 1 |
Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Yates, KA | 1 |
Heymann, H; Mendel, V; Scholz, HC; Simanowski, HJ | 1 |
Fraser, R; Moore, R; Rahmat, R; Shimamura, Y; Walters, R | 1 |
Fraser, R; Moore, R; Rahmat, R; Walters, R | 1 |
Atahan, E; Ergun, Y; Eroglu, E; Gul, M | 1 |
Bouchard, CS; Bu, P; Carey, R; Riske, PS; Zaya, NE | 1 |
Barequet, IS; Belkin, M; Habot-Wilner, Z; Keller, N; Rosner, M; Smollan, G; Ziv, H | 1 |
Goldman, PL; Petersdorf, RG | 1 |
Civiletto, SE; Fisher, JP; Forster, RK | 1 |
Nishi, T; Tsuchiya, K | 1 |
Cantor, JB; Guiboux, JP; Herkowitz, HN; Small, SD; Zervos, M | 1 |
Brandt, CM; Rouse, MS; Steckelberg, JM; Tallan, BM; Wilson, WR | 1 |
Cheadle, WG; Montgomery, WD; Naziri, W; Polk, HC; Trachtenberg, LS | 1 |
Alfaro, DV; Liggett, PE | 1 |
Alfaro, DV; Kirkman, E; Liggett, PE; Runyan, T; Tran, VT | 1 |
Cohen, KL; Lauffenburger, MD | 1 |
Kaiser, AB; Kernodle, DS | 1 |
Aguilar, HE; Drews, C; Gardner, S; Grossniklaus, H; Meredith, TA; Sawant, AD | 1 |
Kim, HK; McGregor, CG; Miller, VM; Odell, J; Park, YS; Steckelberg, JM; Tazelaar, HD | 1 |
Aguilar, HE; Drews, C; Gardner, S; Grossniklaus, HE; Meredith, TA; Sawant, A; Wilson, LA | 1 |
Fernández-Roblas, R; Gadea, I; García-Corbeira, P; Ponte, C; Soriano, F | 1 |
Ahlgren, B; Bernhard, M; Guiboux, JP; Herkowitz, HN; Patti, JE; Zervos, M | 1 |
Kaiser, AB; Kernodle, DS; Kourteva, Y; Menzies, BE | 1 |
Futrell, JW; Roberts, TL; Sande, MA | 1 |
Videau, D | 1 |
Murakawa, T; Nishida, M | 1 |
Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
Callegan, MC; Hill, JM; Hobden, JA; Insler, MS; O'Callaghan, RJ | 2 |
Alfaro, DV; Liggett, PE; Park, J; Pince, K; Runyan, T; Ryan, SJ | 1 |
Kaiser, AB; Kernodle, DS; Parker, RA | 1 |
Ferguson, E; Li, H; Lucia, H; Mansour, AM; Margo, T; Rajashekhar, M | 1 |
Aguilar, HA; Ficker, LA; Gardner, SK; Martin, DF; Meredith, TA; Wilson, LA | 1 |
Calame, W; Craig, WA; Ebert, S; Fantin, B; Leggett, JE; Mattie, H; Totsuka, K; Vogelman, B | 1 |
Bennett, DB; Comereski, CR; Williams, PD | 1 |
Bouffard, JA; Nolan, KD; Petry, NA; Pierson, CL; Schaberg, DR; Spaulding, SA; Stanley, JC; Wakefield, TW; Whitehouse, WM | 1 |
Bloom, JC; Deldar, A; Lewis, HB; Sellers, TS | 1 |
Bloom, JC; Deldar, A; Lewis, HB; Morgan, DG; Sellers, TS | 1 |
66 other study(ies) available for cefazolin and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Impact of Blast Overpressure on the Pharmacokinetics of Various Antibiotics in Sprague Dawley Rats.
Topics: Animals; Anti-Bacterial Agents; Blast Injuries; Cefazolin; Disease Models, Animal; Explosions; Humans; Male; Mice; Rats; Rats, Sprague-Dawley | 2023 |
Evaluation of Blast Overpressure Exposure Effects on Concentration of Antibiotics in Mice.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Blast Injuries; Cefazolin; Disease Models, Animal; Explosions; Mice; Mice, Inbred BALB C; Pressure; ROC Curve | 2020 |
The limitations of mono- and combination antibiotic therapies on immature biofilms in a murine model of implant-associated osteomyelitis.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Bone and Bones; Cefazolin; Disease Models, Animal; Drug Therapy, Combination; Female; Host-Pathogen Interactions; Mice, Inbred BALB C; Osteomyelitis; Prosthesis-Related Infections; Staphylococcus aureus; Treatment Failure | 2021 |
Antibiotic-eluting orthopedic device to prevent early implant associated infections: Efficacy, biocompatibility and biodistribution studies in an ovine model.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Disease Models, Animal; Orthopedic Equipment; Prostheses and Implants; Prosthesis-Related Infections; Sheep; Stainless Steel; Staphylococcal Infections; Staphylococcus aureus | 2018 |
Subcutaneous cefazolin to reduce surgical site infections in a porcine model.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Disease Models, Animal; Female; Injections, Subcutaneous; Surgical Wound Infection; Swine | 2018 |
Chlorhexidine-releasing implant coating on intramedullary nail reduces infection in a rat model.
Topics: Animals; Anti-Bacterial Agents; Betaine; Bone and Bones; Bone Nails; Cefazolin; Chlorhexidine; Coated Materials, Biocompatible; Communicable Diseases; Disease Models, Animal; Drug Liberation; Fracture Fixation, Intramedullary; Fracture Healing; Rats; Titanium | 2018 |
Perioperative use of cefazolin ameliorates postoperative cognitive dysfunction but induces gut inflammation in mice.
Topics: Animals; Anti-Bacterial Agents; Brain; Cefazolin; Cell Line; Cognition Disorders; Colitis; Conditioning, Classical; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Fear; Interleukins; Laparotomy; Male; Maze Learning; Mice; Microglia; Postoperative Complications; RNA, Ribosomal, 16S; Time Factors | 2018 |
Effect of Montelukast, a Cysteinyl Leukotriene Receptor-1 Antagonist, on a Rat Model of Acute Bacterial Sinonasal Inflammation.
Topics: Acetates; Animals; Anti-Bacterial Agents; Cefazolin; Cyclopropanes; Cytokines; Disease Models, Animal; Inflammation; Leukotriene Antagonists; Male; Nasal Septum; Quinolines; Rats; Rats, Wistar; Rhinitis; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Sulfides; Treatment Outcome; Turbinates | 2019 |
Analgesic effect of a single preoperative dose of the antibiotic ceftriaxone in humans.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Animals; Brain; Cefazolin; Ceftriaxone; Decompression, Surgical; Disease Models, Animal; Double-Blind Method; Excitatory Amino Acid Transporter 2; Female; Gene Expression Regulation; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Motor Activity; Pain Measurement; Pain, Postoperative; Peripheral Nervous System Diseases; Rotarod Performance Test; Time Factors | 2013 |
Effects of peritoneal dialysis on pharmacotherapy: a deductive pharmacokinetic-model approach to predict drug concentration profiles in plasma and peritoneal fluid.
Topics: Acute Kidney Injury; Animals; Ascitic Fluid; Cefazolin; Disease Models, Animal; Male; Models, Biological; Peritoneal Dialysis; Propranolol; Protein Binding; Rats, Wistar; Reproducibility of Results; Tolbutamide | 2014 |
Antibiotic penetration into rabbit nucleus pulposus with discitis.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Clindamycin; Discitis; Disease Models, Animal; Female; Intervertebral Disc; Lumbar Vertebrae; Magnetic Resonance Imaging; Male; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 2014 |
An unpredicted side effect of prophylactic antibiotic use.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Cefazolin; Disease Models, Animal; Rats; Rats, Wistar; Skin; Tensile Strength; Wound Healing | 2014 |
Structural changes in albumin are a possible mechanism for fluctuation of cefazorin and ibuprofen plasma protein binding in rats with carcinogen-induced osteosarcoma.
Topics: Albumins; Animals; Blood Proteins; Carcinogens; Cefazolin; Disease Models, Animal; Humans; Ibuprofen; Osteosarcoma; Protein Binding; Rats | 2015 |
Efficacy of Primary Collagen Cross-Linking with Photoactivated Chromophore (PACK-CXL) for the Treatment of Staphylococcus aureus-Induced Corneal Ulcers.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Chloramphenicol; Collagen; Colony Count, Microbial; Cornea; Corneal Pachymetry; Corneal Stroma; Corneal Ulcer; Cross-Linking Reagents; Disease Models, Animal; Eye Infections, Bacterial; Gentamicins; Photosensitizing Agents; Rabbits; Riboflavin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Ultraviolet Rays | 2015 |
[Effect of the Combination of Xiyanping and Cefazolin on the Function of Neutrophils in Mice].
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Chemotaxis; Disease Models, Animal; Drugs, Chinese Herbal; Mice; Neutrophils; Phagocytosis; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Cefazolin and Ertapenem, a Synergistic Combination Used To Clear Persistent Staphylococcus aureus Bacteremia.
Topics: Aged, 80 and over; Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Drug Synergism; Drug Therapy, Combination; Ertapenem; Female; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Staphylococcal Infections; Staphylococcal Skin Infections | 2016 |
Effect of cefazolin and cefuroxime on fracture healing in rats.
Topics: Animals; Anti-Infective Agents; Cefazolin; Cefuroxime; Contraindications; Disease Models, Animal; Femoral Fractures; Femur; Fracture Fixation; Fracture Healing; Fractures, Closed; Male; Rats; Rats, Wistar; Surgical Wound Infection | 2016 |
Better prophylaxis against surgical site infection with local as well as systemic antibiotics. An in vivo study.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Antibiotic Prophylaxis; Cefazolin; Disease Models, Animal; Gentamicins; Injections; Male; Rats; Rats, Sprague-Dawley; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2009 |
The prophylactic effects of platelet-leucocyte gel in osteomyelitis: an experimental study in a rabbit model.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Chronic Disease; Disease Models, Animal; Gels; Leukocyte Transfusion; Osteomyelitis; Platelet Transfusion; Rabbits; Radiography; Staphylococcal Infections; Tibia | 2010 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Effect of intraarticular propolis in an experimental septic arthritis model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Experimental; Arthritis, Infectious; Cartilage, Articular; Cefazolin; Chondrocytes; Disease Models, Animal; Injections, Intra-Articular; Microscopy, Electron, Scanning; Propolis; Rabbits; Stifle; Treatment Outcome | 2011 |
Early antibiotics and debridement independently reduce infection in an open fracture model.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Debridement; Disease Models, Animal; Drug Administration Schedule; Fractures, Open; Male; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Surgical Wound Infection; Time Factors | 2012 |
Effective treatment of osteomyelitis with biodegradable microspheres in a rabbit model.
Topics: Animals; Anti-Bacterial Agents; Biocompatible Materials; Cefazolin; Disease Models, Animal; Drug Carriers; Infusions, Parenteral; Lactic Acid; Male; Microspheres; Osteomyelitis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Polymethyl Methacrylate; Rabbits; Radiography; Radius; Staphylococcal Infections; Tobramycin | 2004 |
Infection prophylaxis of gunshot wounds using probiotics.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Anti-Bacterial Agents; Bacillus subtilis; Bacterial Translocation; Bacterial Vaccines; Cefazolin; Cephalosporins; Disease Models, Animal; Drug Evaluation, Preclinical; Infection Control; Injections, Intramuscular; Probiotics; Rabbits; Random Allocation; Single-Blind Method; Surgical Wound Infection; Therapeutic Irrigation; Treatment Outcome; Wounds, Gunshot | 2004 |
Cefoselis, a beta-lactam antibiotic, easily penetrates the blood-brain barrier and causes seizure independently by glutamate release.
Topics: Animals; Anti-Bacterial Agents; Blood-Brain Barrier; Brain; Cefazolin; Ceftizoxime; Chromatography, High Pressure Liquid; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Male; Microdialysis; Rats; Rats, Wistar; Renal Insufficiency; Seizures | 2004 |
RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Topics: Animals; Anti-Bacterial Agents; Bacteremia; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Imipenem; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Random Allocation; Sensitivity and Specificity; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Vancomycin | 2005 |
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Ofloxacin; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Taurine; Thiadiazines | 2005 |
The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Cefazolin; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2005 |
Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Collagen; Debridement; Disease Models, Animal; Female; Gentamicins; Methylmethacrylates; Osteomyelitis; Pharmaceutical Vehicles; Polymethyl Methacrylate; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2005 |
Prophylactic cephazolin to prevent discitis in an ovine model.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Discitis; Disease Models, Animal; Intervertebral Disc; Male; Orchiectomy; Sheep; Treatment Outcome | 2006 |
Preventing and treating discitis: cephazolin penetration in ovine lumbar intervertebral disc.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Discitis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Intervertebral Disc; Lumbar Vertebrae; Neurosurgical Procedures; Sheep; Treatment Outcome | 2006 |
Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
Topics: Animals; Anti-Bacterial Agents; Blood Vessel Prosthesis; Cefazolin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Male; Methicillin Resistance; Polyethylene Terephthalates; Prosthesis Design; Prosthesis-Related Infections; Rats; Rats, Sprague-Dawley; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
A comparison of topical chlorhexidine, ciprofloxacin, and fortified tobramycin/cefazolin in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Anti-Infective Agents, Local; Cefazolin; Chlorhexidine; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Combinations; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 2007 |
Effect of amniotic membrane transplantation on the healing of bacterial keratitis.
Topics: Amnion; Animals; Anti-Bacterial Agents; Cefazolin; Colony Count, Microbial; Combined Modality Therapy; Corneal Neovascularization; Corneal Opacity; Corneal Ulcer; Disease Models, Animal; Eye Infections, Bacterial; Humans; Male; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Wound Healing | 2008 |
Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
Topics: Animals; beta-Lactamases; Cefazolin; Cephaloridine; Cephalosporins; Cephalothin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Endocarditis, Bacterial; Enzyme Activation; Female; Male; Microbial Sensitivity Tests; Rabbits; Staphylococcal Infections; Staphylococcus aureus | 1980 |
Toxicity, efficacy, and clearance of intravitreally injected of cefazolin.
Topics: Animals; Cefazolin; Disease Models, Animal; Electroretinography; Endophthalmitis; Injections; Ophthalmoscopy; Rabbits; Vitreous Body | 1982 |
Therapeutic effects of cefotiam and cefazolin on experimental pneumonia caused by Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Cefazolin; Cefotiam; Cephalosporins; Disease Models, Animal; Drug Administration Schedule; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Pneumonia | 1980 |
The effect of prophylactic antibiotics on iatrogenic intervertebral disc infections. a rabbit model.
Topics: Animals; Cefazolin; Disease Models, Animal; Iatrogenic Disease; Injections, Intravenous; Intervertebral Disc; Postoperative Complications; Rabbits; Spinal Diseases; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1995 |
Failure of time-kill synergy studies using subinhibitory antimicrobial concentrations to predict in vivo antagonism of cephalosporin-rifampin combinations against Staphylococcus aureus.
Topics: Animals; Cefazolin; Cefpirome; Cephalosporins; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Microbial Sensitivity Tests; Nafcillin; Predictive Value of Tests; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1994 |
Second place winner of the Conrad Jobst Award in the gold medal paper competition. Increased antibiotic effectiveness in a model of surgical infection through continuous infusion.
Topics: Animals; Awards and Prizes; Bacteremia; Cefazolin; Disease Models, Animal; Drug Administration Schedule; Drug Monitoring; General Surgery; Infusions, Intravenous; Kentucky; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Surgical Wound Infection; Survival Rate; Tissue Distribution | 1995 |
Intravenous cefazolin in penetrating eye injuries. I. Effects of trauma and multiple doses on intraocular delivery.
Topics: Animals; Cefazolin; Disease Models, Animal; Eye Injuries, Penetrating; Injections, Intravenous; Rabbits; Sclera; Tissue Distribution; Vitreous Body | 1994 |
Intravenous cefazolin in penetrating eye injuries. Treatment of experimental posttraumatic endophthalmitis.
Topics: Animals; Cefazolin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Eye Injuries, Penetrating; Injections, Intravenous; Limbus Corneae; Pilot Projects; Premedication; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Vitreous Body | 1993 |
Topical ciprofloxacin versus topical fortified antibiotics in rabbit models of Staphylococcus and Pseudomonas keratitis.
Topics: Administration, Topical; Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Cornea; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Keratitis; Ophthalmic Solutions; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin | 1993 |
Comparative prophylactic efficacy of cefazolin and vancomycin in a guinea pig model of Staphylococcus aureus wound infection.
Topics: Animals; Cefazolin; Disease Models, Animal; Female; Guinea Pigs; Male; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Wound Infection | 1993 |
Comparative treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefazolin; Cephalosporins; Combined Modality Therapy; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Eye Infections, Bacterial; Methylprednisolone; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vitrectomy; Vitreous Body | 1996 |
An animal model of pulmonary infection after single lung transplantation.
Topics: Analysis of Variance; Animals; Cefazolin; Clindamycin; Disease Models, Animal; Dogs; Drug Therapy, Combination; Escherichia coli Infections; Gentamicins; Graft Rejection; Immunosuppressive Agents; Lung Transplantation; Male; Neutrophils; Pneumonia, Bacterial; Postoperative Complications; Pulmonary Alveoli; Transplantation, Homologous | 1996 |
Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis.
Topics: Animals; Cefazolin; Cephalosporins; Chemotherapy, Adjuvant; Choroiditis; Corneal Opacity; Dexamethasone; Disease Models, Animal; Endophthalmitis; Eye Diseases; Eye Infections, Bacterial; Glucocorticoids; Methylprednisolone; Necrosis; Rabbits; Retina; Staphylococcal Infections; Staphylococcus aureus; Vitrectomy | 1996 |
Correlation of pharmacodynamic parameters of five beta-lactam antibiotics with therapeutic efficacies in an animal model.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Aztreonam; Cefazolin; Cefotaxime; Disease Models, Animal; Escherichia coli Infections; Male; Mice; Peritoneal Diseases; Piperacillin | 1996 |
The role of prophylactic antibiotics in spinal instrumentation. A rabbit model.
Topics: Animals; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Disease Models, Animal; Intervertebral Disc; Postoperative Complications; Prospective Studies; Rabbits; Reproducibility of Results; Spinal Fusion; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Inhibition of staphylococcal wound infection and potentiation of antibiotic prophylaxis by a recombinant fragment of the fibronectin-binding protein of Staphylococcus aureus.
Topics: Adhesins, Bacterial; Animals; Antibiotic Prophylaxis; Bacterial Proteins; Carrier Proteins; Cefazolin; Cells, Cultured; Cephalosporins; Disease Models, Animal; Drug Synergism; Endothelium, Vascular; Female; Guinea Pigs; Humans; Male; Recombinant Proteins; Staphylococcal Infections; Staphylococcus aureus; Umbilical Veins; Wound Infection | 2002 |
Antibiotic penetration into normal and inflamed tissues as reflected by peripheral lymph.
Topics: Animals; Anti-Bacterial Agents; Blood Proteins; Catheterization; Cefazolin; Cellulitis; Disease Models, Animal; Electrophoresis, Cellulose Acetate; Erythromycin; Inflammation; Injections, Intramuscular; Lymph; Nafcillin; Penicillin G; Proteins; Rabbits | 1979 |
[Experimental pyelonephritis in rats: value in the comparison of antibiotics (author's transl)].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefazolin; Cephaloridine; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Female; Injections, Intramuscular; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Nalidixic Acid; Nitroquinolines; Pyelonephritis; Rats; Rifampin; Sulfamethoxypyridazine; Urine | 1976 |
Exudate levels and bactericidal activity of cefazolin in a new local infection system using rat granuloma pouches.
Topics: Animals; Bacterial Infections; Cefazolin; Cephalosporins; Cephalothin; Disease Models, Animal; Drug Evaluation, Preclinical; Granuloma; Rats | 1977 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
Topical antibiotic therapy for the treatment of experimental Staphylococcus aureus keratitis.
Topics: Animals; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Eye Infections, Bacterial; Keratitis; Microbial Sensitivity Tests; Ophthalmic Solutions; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Systemic antibiotic prophylaxis in penetrating ocular injuries. An experimental study.
Topics: Animals; Anterior Chamber; Cefazolin; Disease Models, Animal; Drug Administration Schedule; Endophthalmitis; Eye Injuries, Penetrating; Gentamicins; Injections, Intravenous; Rabbits; Vitreous Body; Wound Healing | 1992 |
Methicillin-resistant Staphylococcus aureus keratitis in the rabbit: therapy with ciprofloxacin, vancomycin and cefazolin.
Topics: Animals; Cefazolin; Ciprofloxacin; Corneal Ulcer; Disease Models, Animal; Drug Therapy, Combination; Eye Infections, Bacterial; Methicillin Resistance; Ophthalmic Solutions; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1992 |
Low-inoculum model of surgical wound infection.
Topics: Abscess; Ampicillin; Animals; Cefazolin; Disease Models, Animal; Female; Guinea Pigs; Half-Life; Injections, Subcutaneous; Male; Microspheres; Regression Analysis; Staphylococcal Infections; Staphylococcus aureus; Surgical Wound Infection | 1992 |
Vitreous replacement by gas as a therapeutic modality in bacterial endophthalmitis.
Topics: Air; Animals; Aqueous Humor; Cefazolin; Disease Models, Animal; Endophthalmitis; Eye Infections, Bacterial; Fluorocarbons; Rabbits; Random Allocation; Staphylococcal Infections; Staphylococcus aureus; Vitrectomy; Vitreous Body | 1991 |
Vitreous cefazolin levels after intravenous injection. Effects of inflammation, repeated antibiotic doses, and surgery.
Topics: Analysis of Variance; Animals; Anterior Chamber; Aphakia; Cefazolin; Disease Models, Animal; Dose-Response Relationship, Drug; Inflammation; Injections, Intravenous; Pilot Projects; Rabbits; Staphylococcus epidermidis; Uveitis; Vitrectomy; Vitreous Body | 1990 |
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
Topics: Animals; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred ICR; Muscles; Pneumonia | 1989 |
Animal model for evaluating the convulsive liability of beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding, Competitive; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Cyclopropanes; Disease Models, Animal; Drug Combinations; gamma-Aminobutyric Acid; Imipenem; Lactams; Male; Mice; Pentylenetetrazole; Seizures; Thienamycins | 1988 |
Treatment of established prosthetic vascular graft infection with antibiotics preferentially concentrated in leukocytes.
Topics: Animals; Blood Vessel Prosthesis; Cefazolin; Clindamycin; Disease Models, Animal; Dogs; Drug Therapy, Combination; Female; Leukocytes; Rifampin; Staphylococcal Infections; Surgical Wound Infection | 1987 |
The hematologic effects of cefonicid and cefazedone in the dog: a potential model of cephalosporin hematotoxicity in man.
Topics: Anemia; Animals; Cefamandole; Cefazolin; Cefonicid; Cephalosporins; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Hematologic Diseases; Male; Neutropenia; Thrombocytopenia | 1987 |
The hematopathology of cefonicid- and cefazedone-induced blood dyscrasias in the dog.
Topics: Animals; Bone Marrow; Cefamandole; Cefazolin; Cefonicid; Cephalosporins; Disease Models, Animal; Dogs; Hematopoiesis; Liver; Neutrophils; Paraproteinemias | 1987 |